Literature DB >> 4973004

[Studies of the immunbiologic importance of soluble hepatic proteins].

.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 4973004

Source DB:  PubMed          Journal:  Z Gesamte Exp Med        ISSN: 0044-2534


× No keyword cloud information.
  9 in total

1.  Immunological studies on drug-induced allergic hepatitis.

Authors:  Y Mizoguchi; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1976

Review 2.  Autoimmune hepatitis.

Authors:  G Mieli-Vergani; D Vergani
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

3.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

4.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

Review 5.  [Immunologic phenomena in liver diseases: significance of mitochondrial antibodies].

Authors:  P A Berg; D Doniach; I M Roitt
Journal:  Klin Wochenschr       Date:  1969-12-15

6.  [Immunological tolerance].

Authors:  U Hopf
Journal:  Klin Wochenschr       Date:  1971-02-15

7.  Liver specific antigens. Purification and characterization.

Authors:  P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

8.  Studies on drug-induced allergic intrahepatic cholestasis--hepatic cholestasis induced in dogs by lymphocyte culture supernatant.

Authors:  Y Mizoguchi; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1979

9.  Isolation and characterization of a human liver and kidney-specific protein: the hepato-renal (H-R) antigen.

Authors:  S T Nerenberg; R Prasad; P Inboriboon; N Biskup; L Pedersen; I Faiferman
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.